Parichita Mishra
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Parichita Mishra has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Bhisham Narayan Singh
Department of Biotechnology, Manipal School of Life Sciences, Manipal Academy of Higher Education, Manipal, India
2 shared publications - Abhishek Kumar Singh
Manipal Academy of Higher Education
1 shared publication Anuj Mandrekar
1 shared publication- Gopal Shankar Krishnakumar
Department of Biotechnology, Bannari Amman Institute of Technology, Sathyamangalam, Erode, Tamil Nadu, India
1 shared publication - Kanive Parashiva Guruprasad
Centre for Ayurvedic Biology, Department of Ageing Research, Manipal School of Life Sciences, Manipal Academy of Higher Education, Manipal, 576104, Karnataka, India
1 shared publication - Manash Kumar Paul
Department of Radiation Biology and Toxicology, Manipal School of Life Sciences, Manipal Academy of Higher Education, Manipal, India
1 shared publication
Latest Publications
- Open Access
- 4 April 2026
- Published by Elsevier in SSRN Electronic Journal
Design, fabrication, and characterization of biomimetic 3D-printed composite scaffolds with hierarchical porosity gradients for long bone tissue engineering applications
Bone tissue possesses intrinsic capacity to repair noncritical defects; however, regeneration becomes challenging in non-union critical-sized long bone tissue defects. Thus, various types of resorbable grafts as an alternative to autografts were investigated to bridge the non-union gaps. However, the success of such grafts was limited due to its inability to mimic hierarchical bone tissue architecture with a cortical-cancellous gradient limiting proper bone ingrowth, improper vascularization and fails to integrate. Nevertheless, designing scaffolds that effectively mimic the hierarchical organization of cortical-cancellous bone tissue gradients remains a significant challenge. In the present study, a biomimetic computer-aided design (CAD) inspired by leaf venation patterns was developed to establish a hierarchical architecture resembling the transition of cortical to cancellous bone layers in a 3D-printed scaffold. Polycaprolactone (PCL) with various amounts (2.5 - 20% w/v) of hydroxyapatite (HAP) based composite inks were printed with two different needle gauges (22G & 25G), and the resulting scaffolds were systematically characterized for pore size, filament thickness, and mechanical properties to identify the optimal design. To further mimic the native extracellular matrix, gelatin was incorporated as a ground substance within the PCL/HAP skeletal framework. Notably, printed scaffold architecture plays significantly role in establishment of hierarchical pore size gradient across the gelatin phase (Zone B-306 ± 60 µm to Zone E-101 ± 33 µm). Further, in-vitro studies were performed to validate improved cell adhesion, proliferation, and osteogenic differentiation. These findings highlight the potential of biomimetic hierarchical scaffold design combined with ground substance incorporation for bone tissue engineering applications.
- 4 April 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessDesign, fabrication, and characterization of biomimetic 3D-printed composite scaffolds with hierarchical porosity gradients for long bone tissue engineering applications
Bone tissue possesses intrinsic capacity to repair noncritical defects; however, regeneration becomes challenging in non-union critical-sized long bone tissue defects. Thus, various types of resorbable grafts as an alternative to autografts were investigated to bridge the non-union gaps. However, the success of such grafts was limited due to its inability to mimic hierarchical bone tissue architecture with a cortical-cancellous gradient limiting proper bone ingrowth, improper vascularization and fails to integrate. Nevertheless, designing scaffolds that effectively mimic the hierarchical organization of cortical-cancellous bone tissue gradients remains a significant challenge. In the present study, a biomimetic computer-aided design (CAD) inspired by leaf venation patterns was developed to establish a hierarchical architecture resembling the transition of cortical to cancellous bone layers in a 3D-printed scaffold. Polycaprolactone (PCL) with various amounts (2.5 - 20% w/v) of hydroxyapatite (HAP) based composite inks were printed with two different needle gauges (22G & 25G), and the resulting scaffolds were systematically characterized for pore size, filament thickness, and mechanical properties to identify the optimal design. To further mimic the native extracellular matrix, gelatin was incorporated as a ground substance within the PCL/HAP skeletal framework. Notably, printed scaffold architecture plays significantly role in establishment of hierarchical pore size gradient across the gelatin phase (Zone B-306 ± 60 µm to Zone E-101 ± 33 µm). Further, in-vitro studies were performed to validate improved cell adhesion, proliferation, and osteogenic differentiation. These findings highlight the potential of biomimetic hierarchical scaffold design combined with ground substance incorporation for bone tissue engineering applications.
- Open Access
- 19 September 2025
- Published by Zhejiang University Press in Bio-Design and Manufacturing
- Vol. 8 (5) , 877-908
Complexities and challenges associated with articular cartilage tissue defect reconstruction: an overview of bioprinting therapeutics
Osteoarthritis is a common aging-related disorder that is confined mostly to the chondral layer of joints (e.g., the knee) but can spread to bony layers over time. In its early stages, osteoarthritis has minimal symptoms; however, these gradually worsen over time and include joint pain, stiffness, loss of mobility, and inflammation. The exposed subchondral bone of a Grade 4 osteoarthritic knee is highly prone to erosion if left untreated due to persistent rubbing between the bones, which can lead to painful bone spurs. However, treating osteoarthritis is especially challenging due to the poor mitotic potential and low metabolic activity of chondrocytes. Although currently available tissue-engineered products (e.g., BST-CarGel®, TruFit®, and Atelocollagen®) can achieve structural reconstruction and tissue regeneration, final clinical outcomes can still be improved. Major challenges faced during clinical studies of tissue-engineered constructs include chondrocyte hypertrophy and the development of mechanically inferior fibrous tissue, among others. These issues can be addressed by selecting suitable biomaterial combinations, mimicking the three-dimensional (3D) architecture of the tissue matrix, and better controlling inflammation. Furthermore, it is crucial to generate essential signaling molecules within the articular cartilage ecosystem. This approach must also account for the microarchitecture of the affected joint and support the chondrogenic differentiation of mesenchymal stem cells. The use of tissue-engineered constructs has the potential to overcome each of these challenges, since materials can be modified for drug/biomolecule delivery while simultaneously facilitating the regeneration of robust articular cartilage. Three-dimensional printing has been successfully used in tissue engineering to achieve bioprinting. By manipulating conventional 3D printing techniques and the types of bioink used, many different types of bioprinting have emerged. Overall, these bioprinting techniques can be used to address various challenges associated with osteoarthritis treatment.
- 19 September 2025
- Published by Zhejiang University Press in Bio-Design and Manufacturing
- Vol. 8 (5) , 877-908
Open AccessComplexities and challenges associated with articular cartilage tissue defect reconstruction: an overview of bioprinting therapeutics
Osteoarthritis is a common aging-related disorder that is confined mostly to the chondral layer of joints (e.g., the knee) but can spread to bony layers over time. In its early stages, osteoarthritis has minimal symptoms; however, these gradually worsen over time and include joint pain, stiffness, loss of mobility, and inflammation. The exposed subchondral bone of a Grade 4 osteoarthritic knee is highly prone to erosion if left untreated due to persistent rubbing between the bones, which can lead to painful bone spurs. However, treating osteoarthritis is especially challenging due to the poor mitotic potential and low metabolic activity of chondrocytes. Although currently available tissue-engineered products (e.g., BST-CarGel®, TruFit®, and Atelocollagen®) can achieve structural reconstruction and tissue regeneration, final clinical outcomes can still be improved. Major challenges faced during clinical studies of tissue-engineered constructs include chondrocyte hypertrophy and the development of mechanically inferior fibrous tissue, among others. These issues can be addressed by selecting suitable biomaterial combinations, mimicking the three-dimensional (3D) architecture of the tissue matrix, and better controlling inflammation. Furthermore, it is crucial to generate essential signaling molecules within the articular cartilage ecosystem. This approach must also account for the microarchitecture of the affected joint and support the chondrogenic differentiation of mesenchymal stem cells. The use of tissue-engineered constructs has the potential to overcome each of these challenges, since materials can be modified for drug/biomolecule delivery while simultaneously facilitating the regeneration of robust articular cartilage. Three-dimensional printing has been successfully used in tissue engineering to achieve bioprinting. By manipulating conventional 3D printing techniques and the types of bioink used, many different types of bioprinting have emerged. Overall, these bioprinting techniques can be used to address various challenges associated with osteoarthritis treatment.